To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Suppression of HIV replic… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Suppression of HIV replication in vitro by CpG and CpG conjugated to the non toxic B subunit of cholera toxin.

Magazine article
Authors Salma Nowroozalizadeh
Marianne Jansson
Jenni Adamsson
Marianne Lindblad
Eva-Maria Fenyö
Jan Holmgren
Ali M Harandi
Published in Current HIV research
Volume 6
Issue 3
Pages 230-8
ISSN 1873-4251
Publication year 2008
Published at Institute of Biomedicine, Department of Microbiology and Immunology
Pages 230-8
Language en
Links www.ncbi.nlm.nih.gov/entrez/query.f...
Keywords Chemokine CCL3, biosynthesis, immunology, Chemokine CCL4, biosynthesis, immunology, Cholera Toxin, pharmacology, CpG Islands, Cytokines, immunology, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, HIV, drug effects, physiology, HIV Core Protein p24, analysis, immunology, HIV Infections, drug therapy, immunology, virology, HIV-1, drug effects, physiology, HIV-2, drug effects, physiology, Humans, Immunoconjugates, immunology, pharmacology, Leukocytes, Mononuclear, virology, Oligonucleotides, genetics, immunology, pharmacology, Receptors, CCR5, biosynthesis, metabolism, Receptors, CXCR4, biosynthesis, immunology, Virus Replication, drug effects
Subject categories Microbiology in the medical area

Abstract

Administration of oligodeoxynucleotides (ODNs) containing CpG motifs generates a rapid and potent response of CC-chemokines, known as ligands of the HIV-1 co-receptor CCR5, in the murine female genital tract. The present study explored the potential HIV inhibitory activities of different human CpG prototypes either alone or conjugated to the non-toxic subunit of cholera toxin (CTB). Results showed that in vitro replication of both HIV-1 and HIV-2 can be suppressed by different human CpG prototypes. Importantly, the conjugation of CpG ODN to CTB (CTB-CpG) enhanced the antiviral activity of CpG against primary HIV-1 isolates of both R5 and X4 phenotypes in peripheral blood mononuclear cells (PBMC) as well as U87.CD4 co-receptor indicator cells. CTB-CpGs triggered higher amounts of MIP-1alpha, and MIP-1beta in PBMC than the corresponding CpG ODNs, which may explain the superior antiviral effect of CTB-CpG against R5 virus in PBMC. Incubation of PBMC with CpG ODN and CTB-CpG did not alter surface expression of HIV-1 receptors indicating that the observed anti-HIV-1 effect is not mediated through down regulation of HIV-1 receptors on target cells. Further, the enhanced antiviral effect of CTB-CpG was dependent on the presence of phosphorothioate backbone in the ODN, whereas the presence of CpG motif in ODNs was dispensable. These results have implications for the development of novel intervention strategies to prevent HIV infection.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?